Related Experiment Videos
On expert pre-assessment of prospects in clinical trials
Statistics in Medicine
|November 1, 1986
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Compliance with and short-term adverse events from clarithromycin versus placebo in patients with stable coronary heart disease: the CLARICOR trial.
The Journal of antimicrobial chemotherapy·2009
The Osteoporosis Self-Assessment Tool versus alternative tests for selecting postmenopausal women for bone mineral density assessment: a comparative systematic review of accuracy.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2008
Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials.
International journal of epidemiology·2007
Performance of the Osteoporosis Self-Assessment Tool in ruling out low bone mineral density in postmenopausal women: a systematic review.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2007
Performance of four clinical screening tools to select peri- and early postmenopausal women for dual X-ray absorptiometry.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2005
Hybrid Non-Informative and Informative Prior Model-Assisted Designs for Mid-Trial Dose Insertion.
Statistics in medicine·2026
Quantile Tensor Regression for Integrative Genomic Analysis of Oesophageal Carcinoma.
Statistics in medicine·2026
Adaptive Trial Designs for Assessing Predictiveness of a Biomarker in Early Phase Drug Development.
Statistics in medicine·2026
Bias in Meta-Analytic Modeling of Surrogate Endpoints in Cancer Screening Trials.
Statistics in medicine·2026
A Group Structure Guided Ultra-High Dimensional Feature Screening for Survival Outcome.
Statistics in medicine·2026
Gradient Boosting Machine-Based Prognostic Model with SurvSHAP Analysis for Predicting Secondary Loss of Response to Infliximab Therapy in Crohn's Disease.
Drug design, development and therapy·2026
PCBP2 facilitates miR-93-5p-mediated repression of GDF11 in HCC cell lines.
Molecular therapy. Nucleic acids·2026
miRNA-34a-5p is a novel biomarker and modulator of the radioresponse in esophageal adenocarcinoma.
Molecular therapy. Nucleic acids·2026